Back to Search
Start Over
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Feb 28; Vol. 13, pp. 821721. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Many studies already reported on the association between patient characteristics on the severity of COVID-19 disease outcome, but the relation with SARS-CoV-2 antibody levels is less clear. To investigate this in more detail, we performed a retrospective observational study in which we used the IgG antibody response from 11,118 longitudinal antibody measurements of 2,082 unique COVID convalescent plasma donors. COVID-19 symptoms and donor characteristics were obtained by a questionnaire. Antibody responses were modelled using a linear mixed-effects model. Our study confirms that the SARS-CoV-2 antibody response is associated with patient characteristics like body mass index and age. Antibody decay was faster in male than in female donors (average half-life of 62 versus 72 days). Most interestingly, we also found that three symptoms (headache, anosmia, nasal cold) were associated with lower peak IgG, while six other symptoms (dry cough, fatigue, diarrhoea, fever, dyspnoea, muscle weakness) were associated with higher IgG concentrations.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Vinkenoog, Steenhuis, Brinke, van Hasselt, Janssen, van Leeuwen, Swaneveld, Vrielink, van de Watering, Quee, van den Hurk, Rispens, Hogema and van der Schoot.)
- Subjects :
- Adult
Antibodies, Viral blood
Antibody Formation
Blood Donors
Body Mass Index
COVID-19 epidemiology
COVID-19 physiopathology
Convalescence
Female
Humans
Immunization, Passive methods
Immunoglobulin G blood
Male
Middle Aged
Netherlands epidemiology
Retrospective Studies
COVID-19 Serotherapy
Age Factors
COVID-19 immunology
COVID-19 therapy
SARS-CoV-2 physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 35296077
- Full Text :
- https://doi.org/10.3389/fimmu.2022.821721